HST
52
4
COP
45
-2
UPS
55
4
CMS
67
2
MAR
50
6
TROW
59
-2
ABT
48
3
DE
30
-10
PCAR
53
-3
MSFT
62
-2
UHS
64
-2
CHD
64
-3
SE
57
7
ADM
39
5
DHI
53
-4
GWW
55
-9
PNR
65
-4
GOOGL
72
13
IP
65
3
MAC
77
2
HST
52
4
COP
45
-2
UPS
55
4
CMS
67
2
MAR
50
6
TROW
59
-2
ABT
48
3
DE
30
-10
PCAR
53
-3
MSFT
62
-2
UHS
64
-2
CHD
64
-3
SE
57
7
ADM
39
5
DHI
53
-4
GWW
55
-9
PNR
65
-4
GOOGL
72
13
IP
65
3
MAC
77
2
Financhill
Back

Verona Pharma PLC Quote, Financials, Valuation and Earnings

Sell
48

VRNA
Verona Pharma PLC

Last Price:
13.03
Seasonality Move:
51.74%

7 Day Trial

ALL ACCESS PASS

$ 7

Verona Pharma PLC Price Quote

$13.03
-0.33 (-2.47%)
(Updated: May 17, 2024 at 6:55 PM ET)

Verona Pharma PLC Key Stats

Sell
48
Verona Pharma PLC (VRNA) is a Sell
Day range:
$13.33 - $14.12
52-week range:
$11.83 - $23.07
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
4.81%
Volume:
721.5K
Avg. volume:
493.5K
1-year change:
-32.25%
Market cap:
$1.1B
Revenue:
$0
EPS:
$-0.8

How Much Does Verona Pharma PLC Make?

Data Unavailable

Is Verona Pharma PLC Growing As A Company?

Data Unavailable

Verona Pharma PLC Stock Price Performance

  • Did Verona Pharma PLC Stock Go Up Last Month?
    Verona Pharma PLC share price went down by -17.53% last month
  • Did VRNA's Share Price Rise Over The Last Year?
    VRNA share price fell by -32.25% over the past 1 year

What Is Verona Pharma PLC 52-Week High & Low?

Verona Pharma PLC Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Verona Pharma PLC?

  • How Much Debt Does Verona Pharma PLC Have?
    Total long term debt quarterly is $0
  • How Much Cash Does Verona Pharma PLC Have?
    Cash and short term investments quarterly total is $254.9M
  • What Is Verona Pharma PLC’s Book Value Per Share?
    Book value per share is 2.78

Is Verona Pharma PLC Cash Flow Positive?

  • What Is VRNA Cash Flow From Operations?
    Cash flow from operations (TTM) is -$58.1M
  • What Is Verona Pharma PLC’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $21.1M
  • What Is Verona Pharma PLC’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$16K

Verona Pharma PLC Return On Invested Capital

Data Unavailable

Verona Pharma PLC Earnings Date & Stock Price

Verona Pharma PLC Competitors

  • Who Are Verona Pharma PLC's Competitors?
    Below is a list of companies who compete with Verona Pharma PLC or are related in some way:
    • Adaptimmune Therapeutics PLC (ADAP)
    • Bicycle Therapeutics PLC (BCYC)
    • Biodexa Pharmaceuticals Plc (BDRX)
    • NuCana PLC (NCNA)
    • TC BioPharm (Holdings) PLC (TCBP)

Verona Pharma PLC Dividend Yield

Data Unavailable

Verona Pharma PLC Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 69.57%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 5
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 34.29
Upside from Last Price: 156.63%

Major Shareholders

  • How many VRNA shares are owned by institutional investors?
    84.5M VRNA shares are owned by institutional investors
  • How many VRNA shares are owned by insiders?
    42.2M VRNA shares are owned by insiders